1112 On Other Exchanges
Symbol
Exchange
1112 is not on other exchanges.

biostime international holdi (1112) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOSTIME INTERNATIONAL HOLDI (1112)

Related News

No related news articles were found.

biostime international holdi (1112) Related Businessweek News

No Related Businessweek News Found

biostime international holdi (1112) Details

Biostime International Holdings Limited, an investment holding company, provides pediatric nutritional and baby care products to mothers primarily in the People’s Republic of China. The company operates through five segments: Infant Formulas, Adult Nutrition and Care Products, Probiotic Supplements, Dried Baby Food and Nutrition Supplements, and Baby Care Products. The Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment offers vitamins, health supplements, and skin care and sports nutrition products for adults. The Probiotic Supplements segment produces probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The Dried Baby Food and Nutrition Supplements segment engages in the production of dried baby food products made from natural foods for infants and young children; and microencapsulated milk calcium chewable tablets for children, and pregnant and lactating mothers. The Baby Care Products segment provides baby care products for infants and children, including baby diapers and toiletry kits, as well as personal care products for nursing mothers, such as nursing pads. The company is also involved in the wholesale, retail, import, and export of personal care products for infants; trading of infant food and nutritional products; early childhood education advisory business; and trading of related baby supplies, as well as offers online software and information technology services. It sells its products and services through distributors under the Biostime, Adimil, BMcare, and Parenting Power brands. The company was founded in 1999 and is headquartered in Guangzhou, China. Biostime International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.

Founded in 1999

biostime international holdi (1112) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY6.5M
Compensation as of Fiscal Year 2015.

biostime international holdi (1112) Key Developments

Biostime International Holdings Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016

Biostime International Holdings Limited announced unaudited consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported revenue of RMB 3,008,304,000 against RMB 1,962,902,000 a year ago. The increase in revenue was mainly attributable to the enlarged product segment of adult nutrition and care under the 'Swisse' brand. Profit before tax was RMB 661,751,000 against RMB 280,118,000 a year ago. Profit for the period attributable to owners of the parent was RMB 356,909,000 or RMB 0.56 per diluted share against RMB 204,955,000 or RMB 0.33 per diluted share a year ago. Net cash flows from operating activities were RMB 551,440,000 against RMB 147,428,000 a year ago. EBITDA was RMB 949,948,000 against RMB 295,176,000 a year ago. This increase was mainly due to the contribution from Swisse's operations. Purchases of items of property, plant and equipment was RMB 53,084,000 against RMB 62,600,000 a year ago. Purchases of items of intangible assets were RMB 8,081,000 against RMB 688,000 a year ago.

Biostime International Holdings Limited (China), Special/Extraordinary Shareholders Meeting, Sep 13, 2016

Biostime International Holdings Limited (China), Special/Extraordinary Shareholders Meeting, Sep 13, 2016, at 09:30 China Standard Time. Location: 29/F, Guangzhou International Finance Center 5 Zhujiang West Road, Zhujiang New Town, Tianhe District, Guangzhou, Guangdong Province China

Biostime International Holdings Limited (China) Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016

Biostime International Holdings Limited (China) reported unaudited consolidated earnings results for the six months ended June 30, 2016. For the period, revenue was RMB 3,008.304 million against RMB 1,962.902 million a year ago. Profit before tax was RMB 661.751 million against RMB 280.118 million a year ago. Profit attributable to owners of the parent was RMB 356.909 million or RMB 0.56 per diluted share against RMB 204.955 million or RMB 0.33 per diluted share a year ago. Net cash flows from operating activities amounted to RMB 551.440 million comparing to RMB 147.4 million a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1112 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1112.
View Industry Companies
 

Industry Analysis

1112

Industry Average

Valuation 1112 Industry Range
Price/Earnings 27.8x
Price/Sales 1.9x
Price/Book 2.9x
Price/Cash Flow 27.7x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BIOSTIME INTERNATIONAL HOLDI, please visit www.biostime.com.cn. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.